NCT07225244 Comparative Outcomes of Four Versus Two Balloon Inflation Points in Dacryoplasty for Primary Acquired Nasolacrimal Duct Obstruction
| NCT ID | NCT07225244 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Primary Acquired Nasolacrimal Duct Obstruction |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2025-11 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2025-11 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Primary acquired nasolacrimal duct obstruction
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with primary acquired nasolacrimal duct obstruction (PANDO) Exclusion Criteria: * Patients who are pregnant, with previous lacrimal procedure, upper lacrimal drainage obstruction, punctal stenosis, active dacryocystitis, dacryolithiasis, traumatic obstruction or lacrimal mass
Contact & Investigator
Yi-Hsuan Wei, PhD
PRINCIPAL INVESTIGATOR
National Taiwan University Hospital
Frequently Asked Questions
Who can join the NCT07225244 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Primary Acquired Nasolacrimal Duct Obstruction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07225244 currently recruiting?
Yes, NCT07225244 is actively recruiting participants. Contact the research team at wn0069@yahoo.com.tw for enrollment information.
Where is the NCT07225244 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07225244 clinical trial?
NCT07225244 is sponsored by National Taiwan University Hospital. The principal investigator is Yi-Hsuan Wei, PhD at National Taiwan University Hospital. The trial plans to enroll 50 participants.